News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AdAlta.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who’s taking matters into their own hands today?
Health & Biotech
ASX Health Stocks: Aussie biotechs Argenica and Antisense take major steps in the US
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
News
Closing Bell: ASX has its worst day since February, suffering 2.1pc drop
Health & Biotech
CAR-T therapy is potentially a $20bn market. Here’s how it works and the ASX players in the space
Health & Biotech
ASX Health Stocks: Nanosonics jumps almost 20% as revenue momentum picks up steam
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
News
Market highlights and 5 ASX small caps to watch on Wednesday
News
ASX Small Cap Lunch Wrap: Who’s cruising for a bruising today?
Health & Biotech
AdAlta soars after getting orphan drug designation for its shark-based drug
News
10 at 10: These ASX stocks are soaring ahead this morning
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
Health & Biotech
Health Kick: Investors eye AdAlta’s fibrosis fighting i-body platform
Stockhead TV
VIDEO: 90 Seconds With…Tim Oldham, AdAlta
News
Rise and Shine: What you need to know before the ASX opens
News
